Loading…
Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer
Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapie...
Saved in:
Published in: | Cancer control 2024-08, Vol.31, p.10732748241280444 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713 |
container_end_page | |
container_issue | |
container_start_page | 10732748241280444 |
container_title | Cancer control |
container_volume | 31 |
creator | Yu, Alice Dinckal, Mustafa Pow-Sang, Julio |
description | Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes. |
doi_str_mv | 10.1177/10732748241280444 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2edf5b65b1404c82a15976f434f348c0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_10732748241280444</sage_id><doaj_id>oai_doaj_org_article_2edf5b65b1404c82a15976f434f348c0</doaj_id><sourcerecordid>3101795453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS0EoqXwA7igSFy4pHhsJ7aP1QraikpUbRFHa-KMt15lk8VOkPj3uGxpJSpOtp6_eTOex9hb4McAWn8ErqXQyggFwnCl1DN2CI1oayEb-7zcy3t9BxywVzlvOBdcSfWSHUgrlIRWHrIv10taR49DddINOMefVN3cUsJdpFzFsbosGo1zrr7H-ba6wj5OifySUhGryzTlGWeqVjh6Sq_Zi4BDpjf35xH79vnTzeqsvvh6er46uah9GWuurQ7IKehAvhNKo--0B-I9iCa0Rhjfa26MLRiXXnKQ1AFC25tgPRgN8oid7337CTdul-IW0y83YXR_hCmtHaY5-oGcoD40Xdt0oLjyRiA0VrehbCFIZTwvXh_2Xrs0_Vgoz24bs6dhwJGmJTsJHLRtVCML-v4fdDMtaSw_LZSyWoMFVSjYU74sJycKDwMCd3epuSeplZp3985Lt6X-oeJvTAU43gMZ1_TY9v-OvwH8Mpzz</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149771914</pqid></control><display><type>article</type><title>Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer</title><source>NCBI_PubMed Central(免费)</source><source>Publicly Available Content Database</source><source>Sage Journals GOLD Open Access 2024</source><creator>Yu, Alice ; Dinckal, Mustafa ; Pow-Sang, Julio</creator><creatorcontrib>Yu, Alice ; Dinckal, Mustafa ; Pow-Sang, Julio</creatorcontrib><description>Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes.</description><identifier>ISSN: 1073-2748</identifier><identifier>ISSN: 1526-2359</identifier><identifier>EISSN: 1526-2359</identifier><identifier>DOI: 10.1177/10732748241280444</identifier><identifier>PMID: 39243163</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Ablation Techniques - methods ; Cancer therapies ; Disease management ; Humans ; Male ; Neoplasm Recurrence, Local ; Prostate cancer ; Prostatectomy ; Prostatectomy - methods ; Prostatic Neoplasms - radiotherapy ; Prostatic Neoplasms - surgery ; Radiation therapy ; Salvage Therapy - methods ; Treatment Outcome</subject><ispartof>Cancer control, 2024-08, Vol.31, p.10732748241280444</ispartof><rights>The Author(s) 2024</rights><rights>The Author(s) 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713</cites><orcidid>0000-0001-9815-3619 ; 0000-0003-4905-1602 ; 0000-0003-1827-6585</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/10732748241280444$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3149771914?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>313,314,780,784,792,21964,25751,27851,27920,27922,27923,37010,37011,44588,44943,45331</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39243163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Alice</creatorcontrib><creatorcontrib>Dinckal, Mustafa</creatorcontrib><creatorcontrib>Pow-Sang, Julio</creatorcontrib><title>Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer</title><title>Cancer control</title><addtitle>Cancer Control</addtitle><description>Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes.</description><subject>Ablation Techniques - methods</subject><subject>Cancer therapies</subject><subject>Disease management</subject><subject>Humans</subject><subject>Male</subject><subject>Neoplasm Recurrence, Local</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>Prostatectomy - methods</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Radiation therapy</subject><subject>Salvage Therapy - methods</subject><subject>Treatment Outcome</subject><issn>1073-2748</issn><issn>1526-2359</issn><issn>1526-2359</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kUFv1DAQhS0EoqXwA7igSFy4pHhsJ7aP1QraikpUbRFHa-KMt15lk8VOkPj3uGxpJSpOtp6_eTOex9hb4McAWn8ErqXQyggFwnCl1DN2CI1oayEb-7zcy3t9BxywVzlvOBdcSfWSHUgrlIRWHrIv10taR49DddINOMefVN3cUsJdpFzFsbosGo1zrr7H-ba6wj5OifySUhGryzTlGWeqVjh6Sq_Zi4BDpjf35xH79vnTzeqsvvh6er46uah9GWuurQ7IKehAvhNKo--0B-I9iCa0Rhjfa26MLRiXXnKQ1AFC25tgPRgN8oid7337CTdul-IW0y83YXR_hCmtHaY5-oGcoD40Xdt0oLjyRiA0VrehbCFIZTwvXh_2Xrs0_Vgoz24bs6dhwJGmJTsJHLRtVCML-v4fdDMtaSw_LZSyWoMFVSjYU74sJycKDwMCd3epuSeplZp3985Lt6X-oeJvTAU43gMZ1_TY9v-OvwH8Mpzz</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Yu, Alice</creator><creator>Dinckal, Mustafa</creator><creator>Pow-Sang, Julio</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9815-3619</orcidid><orcidid>https://orcid.org/0000-0003-4905-1602</orcidid><orcidid>https://orcid.org/0000-0003-1827-6585</orcidid></search><sort><creationdate>20240801</creationdate><title>Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer</title><author>Yu, Alice ; Dinckal, Mustafa ; Pow-Sang, Julio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Ablation Techniques - methods</topic><topic>Cancer therapies</topic><topic>Disease management</topic><topic>Humans</topic><topic>Male</topic><topic>Neoplasm Recurrence, Local</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>Prostatectomy - methods</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Radiation therapy</topic><topic>Salvage Therapy - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Alice</creatorcontrib><creatorcontrib>Dinckal, Mustafa</creatorcontrib><creatorcontrib>Pow-Sang, Julio</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Alice</au><au>Dinckal, Mustafa</au><au>Pow-Sang, Julio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer</atitle><jtitle>Cancer control</jtitle><addtitle>Cancer Control</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>31</volume><spage>10732748241280444</spage><pages>10732748241280444-</pages><issn>1073-2748</issn><issn>1526-2359</issn><eissn>1526-2359</eissn><abstract>Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>39243163</pmid><doi>10.1177/10732748241280444</doi><orcidid>https://orcid.org/0000-0001-9815-3619</orcidid><orcidid>https://orcid.org/0000-0003-4905-1602</orcidid><orcidid>https://orcid.org/0000-0003-1827-6585</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-2748 |
ispartof | Cancer control, 2024-08, Vol.31, p.10732748241280444 |
issn | 1073-2748 1526-2359 1526-2359 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_2edf5b65b1404c82a15976f434f348c0 |
source | NCBI_PubMed Central(免费); Publicly Available Content Database; Sage Journals GOLD Open Access 2024 |
subjects | Ablation Techniques - methods Cancer therapies Disease management Humans Male Neoplasm Recurrence, Local Prostate cancer Prostatectomy Prostatectomy - methods Prostatic Neoplasms - radiotherapy Prostatic Neoplasms - surgery Radiation therapy Salvage Therapy - methods Treatment Outcome |
title | Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A42%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20Ablative%20Therapies%20in%20Patients%20With%20Radiorecurrent%20Prostate%20Cancer&rft.jtitle=Cancer%20control&rft.au=Yu,%20Alice&rft.date=2024-08-01&rft.volume=31&rft.spage=10732748241280444&rft.pages=10732748241280444-&rft.issn=1073-2748&rft.eissn=1526-2359&rft_id=info:doi/10.1177/10732748241280444&rft_dat=%3Cproquest_doaj_%3E3101795453%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3149771914&rft_id=info:pmid/39243163&rft_sage_id=10.1177_10732748241280444&rfr_iscdi=true |